References
- LacroJPDunnLBDolderCRLeckbandSGJesteDVPrevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literatureJ Clin Psychiatry2002631089290912416599
- SajatovicMValensteinMBlowFCGanoczyDIgnacioRVTreatment adherence with antipsychotic medications in bipolar disorderBipolar Disord20068323224116696824
- HungCIFactors predicting adherence to antidepressant treatmentCurr Opin Psychiatry201427534434925033275
- Ascher-SvanumHFariesDEZhuBErnstFRSwartzMSSwansonJWMedication adherence and long-term functional outcomes in the treatment of schizophrenia in usual careJ Clin Psychiatry200667345346016649833
- HongJReedCNovickDHaroJMAguadoJClinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) studyPsychiatry Res2011190111011421571375
- ScottJPopeMSelf-reported adherence to treatment with mood stabi-lizers, plasma levels, and psychiatric hospitalizationAm J Psychiatry2002159111927192912411230
- VelliganDILamYWGlahnDCDefining and assessing adherence to oral antipsychotics: a review of the literatureSchizophr Bull200632472474216707778
- VelliganDWangMDiamondPRelationships among subjective and objective measures of adherence to oral antipsychotic medicationsPsychiatr Serv20075891187119217766564
- SajatovicMVelliganDIWeidenPJValensteinMAOgedegbeGMeasurement of psychiatric treatment adherenceJ Psychosom Res201069659159921109048
- GallowayGPCoyleJRGuillenJEFlowerKMendelsonJEA simple, novel method for assessing medication adherence: capsule photographs taken with cellular telephonesJ Addict Med20115317017421844832
- Abilify® (aripiprazole) [prescribing information]Tokyo, JapanOtsuka Pharmaceutical Co., Ltd.2016
- ShafrinJSchwartzTTLakdawallaDNFormaFMEstimating the value of new technologies that provide more accurate drug adherence information to providers for their patients with schizophreniaJ Manag Care Spec Pharm201622111285129127783545
- ProfitDRohatagiSZhaoCHatchADochertyJPPeters-StricklandTSDeveloping a digital medicine system in psychiatry: ingestion detection rate and latency periodJ Clin Psychiatry2016779e1095e110027379966
- Au-YeungKYMoonGDRobertsonTLEarly clinical experience with networked system for promoting patient self-managementAm J Manag Care2011177e277e28721819175
- KaneJMPerlisRHDiCarloLAAu-YeungKDuongJPetridesGFirst experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorderJ Clin Psychiatry2013746e533e54023842023
- Peters-StricklandTPestreichLHatchAUsability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazoleNeuropsychiatr Dis Treat2016122587259427785036
- RohatagiSProfitDHatchAZhaoCDochertyJPPeters-StricklandTSOptimization of a digital medicine system in psychiatryJ Clin Psychiatry2016779e1101e110727487251
- Ben-ZeevDKaiserSMBrennerCJBegaleMDuffecyJMohrDCDevelopment and usability testing of FOCUS: a smartphone system for self-management of schizophreniaPsychiatr Rehabil J201336428929624015913
- Ben-ZeevDBrennerCJBegaleMDuffecyJMohrDCMueserKTFeasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophreniaSchizophr Bull20144061244125324609454
- Advancing Safety in Medical TechnologyANSI/AAMI HE75: Human Factors Engineering–Design of Medical DevicesArlington, VAAssociation for the Advancement of Medical Instrumentation2009
- US Department of Health and Human Services, US Food and Drug AdministrationApplying Human Factors and Usability Engineering to Medical Devices: Draft Guidance for Industry and Food and Drug Administration staff2016 Available from: https://www.fda.gov/downloads/MedicalDevices/.../UCM259760.pdfAccessed July 11, 2017
- US Department of Health and Human Services, US Food and Drug Administration, Center for Drug Evaluation and ResearchSafety Considerations for Product Design to Minimize Medication Errors2016 Available from: https://www.fda.gov/downloads/drugs/guidance-complianceregulatoryinformation/guidances/ucm331810.pdfAccessed July 11, 2017
- RotondiAJEackSMHanusaBHSpringMBHaasGLCritical design elements of e-health applications for users with severe mental illness: singular focus, simple architecture, prominent contents, explicit navigation, and inclusive hyperlinksSchizophr Bull201541244044824375458